Seeking Alpha

Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes...

Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes equipment used by blood banks, hospitals, and labs to test blood prior to transfusions. (PR) Good call by Andrew August back in March.
From other sites
Comments (1)
  • Ed's perspective
    , contributor
    Comments (262) | Send Message
     
    Tip of the hat Andrew ...... well done.
    5 Jul 2011, 11:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs